img

Global RNA Vaccines Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global RNA Vaccines Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of RNA has greatly favored the development of in vivo transfection strategies.
RNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of RNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.
RNA Vaccines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global RNA Vaccines market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Infectious Disease and Cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for RNA Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, RNA Vaccines key manufacturers include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA and Ethris, etc. Moderna Therapeutics, CureVac, Translate Bio are top 3 players and held % sales share in total in 2022.
RNA Vaccines can be divided into Individualized Cancer Treatment MRNA Vaccine, Infectious Disease Treatment MRNA Vaccine and Infection Prevention MRNA Vaccine,, etc. Individualized Cancer Treatment MRNA Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
RNA Vaccines is widely used in various fields, such as Infectious Disease, Cancer and Other,, etc. Infectious Disease provides greatest supports to the RNA Vaccines industry development. In 2022, global % sales of RNA Vaccines went into Infectious Disease filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global RNA Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Segment by Type
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine

Segment by Application


Infectious Disease
Cancer
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the RNA Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of RNA Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the RNA Vaccines industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of RNA Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, RNA Vaccines introduction, etc. RNA Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of RNA Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 RNA Vaccines Market Overview
1.1 RNA Vaccines Product Overview
1.2 RNA Vaccines Market Segment by Type
1.2.1 Individualized Cancer Treatment MRNA Vaccine
1.2.2 Infectious Disease Treatment MRNA Vaccine
1.2.3 Infection Prevention MRNA Vaccine
1.3 Global RNA Vaccines Market Size by Type
1.3.1 Global RNA Vaccines Market Size Overview by Type (2024-2034)
1.3.2 Global RNA Vaccines Historic Market Size Review by Type (2024-2024)
1.3.3 Global RNA Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America RNA Vaccines Sales Breakdown by Type (2024-2024)
1.4.2 Europe RNA Vaccines Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific RNA Vaccines Sales Breakdown by Type (2024-2024)
1.4.4 Latin America RNA Vaccines Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa RNA Vaccines Sales Breakdown by Type (2024-2024)
2 Global RNA Vaccines Market Competition by Company
2.1 Global Top Players by RNA Vaccines Sales (2024-2024)
2.2 Global Top Players by RNA Vaccines Revenue (2024-2024)
2.3 Global Top Players by RNA Vaccines Price (2024-2024)
2.4 Global Top Manufacturers RNA Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 RNA Vaccines Market Competitive Situation and Trends
2.5.1 RNA Vaccines Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by RNA Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in RNA Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into RNA Vaccines Market
2.8 Key Manufacturers RNA Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 RNA Vaccines Status and Outlook by Region
3.1 Global RNA Vaccines Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global RNA Vaccines Historic Market Size by Region
3.2.1 Global RNA Vaccines Sales in Volume by Region (2024-2024)
3.2.2 Global RNA Vaccines Sales in Value by Region (2024-2024)
3.2.3 Global RNA Vaccines Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global RNA Vaccines Forecasted Market Size by Region
3.3.1 Global RNA Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global RNA Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global RNA Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global RNA Vaccines by Application
4.1 RNA Vaccines Market Segment by Application
4.1.1 Infectious Disease
4.1.2 Cancer
4.1.3 Other
4.2 Global RNA Vaccines Market Size by Application
4.2.1 Global RNA Vaccines Market Size Overview by Application (2024-2034)
4.2.2 Global RNA Vaccines Historic Market Size Review by Application (2024-2024)
4.2.3 Global RNA Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America RNA Vaccines Sales Breakdown by Application (2024-2024)
4.3.2 Europe RNA Vaccines Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific RNA Vaccines Sales Breakdown by Application (2024-2024)
4.3.4 Latin America RNA Vaccines Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa RNA Vaccines Sales Breakdown by Application (2024-2024)
5 North America RNA Vaccines by Country
5.1 North America RNA Vaccines Historic Market Size by Country
5.1.1 North America RNA Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America RNA Vaccines Sales in Volume by Country (2024-2024)
5.1.3 North America RNA Vaccines Sales in Value by Country (2024-2024)
5.2 North America RNA Vaccines Forecasted Market Size by Country
5.2.1 North America RNA Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America RNA Vaccines Sales in Value by Country (2024-2034)
6 Europe RNA Vaccines by Country
6.1 Europe RNA Vaccines Historic Market Size by Country
6.1.1 Europe RNA Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe RNA Vaccines Sales in Volume by Country (2024-2024)
6.1.3 Europe RNA Vaccines Sales in Value by Country (2024-2024)
6.2 Europe RNA Vaccines Forecasted Market Size by Country
6.2.1 Europe RNA Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe RNA Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific RNA Vaccines by Region
7.1 Asia-Pacific RNA Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific RNA Vaccines Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific RNA Vaccines Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific RNA Vaccines Sales in Value by Region (2024-2024)
7.2 Asia-Pacific RNA Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific RNA Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific RNA Vaccines Sales in Value by Region (2024-2034)
8 Latin America RNA Vaccines by Country
8.1 Latin America RNA Vaccines Historic Market Size by Country
8.1.1 Latin America RNA Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America RNA Vaccines Sales in Volume by Country (2024-2024)
8.1.3 Latin America RNA Vaccines Sales in Value by Country (2024-2024)
8.2 Latin America RNA Vaccines Forecasted Market Size by Country
8.2.1 Latin America RNA Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America RNA Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa RNA Vaccines by Country
9.1 Middle East and Africa RNA Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa RNA Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa RNA Vaccines Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa RNA Vaccines Sales in Value by Country (2024-2024)
9.2 Middle East and Africa RNA Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa RNA Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa RNA Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Moderna Therapeutics
10.1.1 Moderna Therapeutics Company Information
10.1.2 Moderna Therapeutics Introduction and Business Overview
10.1.3 Moderna Therapeutics RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Moderna Therapeutics RNA Vaccines Products Offered
10.1.5 Moderna Therapeutics Recent Development
10.2 CureVac
10.2.1 CureVac Company Information
10.2.2 CureVac Introduction and Business Overview
10.2.3 CureVac RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.2.4 CureVac RNA Vaccines Products Offered
10.2.5 CureVac Recent Development
10.3 Translate Bio
10.3.1 Translate Bio Company Information
10.3.2 Translate Bio Introduction and Business Overview
10.3.3 Translate Bio RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Translate Bio RNA Vaccines Products Offered
10.3.5 Translate Bio Recent Development
10.4 BioNTech
10.4.1 BioNTech Company Information
10.4.2 BioNTech Introduction and Business Overview
10.4.3 BioNTech RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.4.4 BioNTech RNA Vaccines Products Offered
10.4.5 BioNTech Recent Development
10.5 Sangamo Therapeutics
10.5.1 Sangamo Therapeutics Company Information
10.5.2 Sangamo Therapeutics Introduction and Business Overview
10.5.3 Sangamo Therapeutics RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Sangamo Therapeutics RNA Vaccines Products Offered
10.5.5 Sangamo Therapeutics Recent Development
10.6 Argos Therapeutics
10.6.1 Argos Therapeutics Company Information
10.6.2 Argos Therapeutics Introduction and Business Overview
10.6.3 Argos Therapeutics RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Argos Therapeutics RNA Vaccines Products Offered
10.6.5 Argos Therapeutics Recent Development
10.7 In-Cell-Art
10.7.1 In-Cell-Art Company Information
10.7.2 In-Cell-Art Introduction and Business Overview
10.7.3 In-Cell-Art RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.7.4 In-Cell-Art RNA Vaccines Products Offered
10.7.5 In-Cell-Art Recent Development
10.8 eTheRNA
10.8.1 eTheRNA Company Information
10.8.2 eTheRNA Introduction and Business Overview
10.8.3 eTheRNA RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.8.4 eTheRNA RNA Vaccines Products Offered
10.8.5 eTheRNA Recent Development
10.9 Ethris
10.9.1 Ethris Company Information
10.9.2 Ethris Introduction and Business Overview
10.9.3 Ethris RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Ethris RNA Vaccines Products Offered
10.9.5 Ethris Recent Development
10.10 Tiba Biotechnology
10.10.1 Tiba Biotechnology Company Information
10.10.2 Tiba Biotechnology Introduction and Business Overview
10.10.3 Tiba Biotechnology RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Tiba Biotechnology RNA Vaccines Products Offered
10.10.5 Tiba Biotechnology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 RNA Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 RNA Vaccines Industrial Chain Analysis
11.4 RNA Vaccines Market Dynamics
11.4.1 RNA Vaccines Industry Trends
11.4.2 RNA Vaccines Market Drivers
11.4.3 RNA Vaccines Market Challenges
11.4.4 RNA Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 RNA Vaccines Distributors
12.3 RNA Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Individualized Cancer Treatment MRNA Vaccine
Table 2. Major Company of Infectious Disease Treatment MRNA Vaccine
Table 3. Major Company of Infection Prevention MRNA Vaccine
Table 4. Global RNA Vaccines Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global RNA Vaccines Sales by Type (2024-2024) & (K Doses)
Table 6. Global RNA Vaccines Sales Market Share in Volume by Type (2024-2024)
Table 7. Global RNA Vaccines Sales by Type (2024-2024) & (US& Million)
Table 8. Global RNA Vaccines Market Share in Value by Type (2024-2024)
Table 9. Global RNA Vaccines Price by Type (2024-2024) & (USD/Dose)
Table 10. Global RNA Vaccines Sales by Type (2024-2034) & (K Doses)
Table 11. Global RNA Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 12. Global RNA Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 13. Global RNA Vaccines Sales Market Share in Value by Type (2024-2034)
Table 14. Global RNA Vaccines Price by Type (2024-2034) & (USD/Dose)
Table 15. North America RNA Vaccines Sales by Type (2024-2024) & (K Doses)
Table 16. North America RNA Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe RNA Vaccines Sales (K Doses) by Type (2024-2024)
Table 18. Europe RNA Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific RNA Vaccines Sales (K Doses) by Type (2024-2024)
Table 20. Asia-Pacific RNA Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America RNA Vaccines Sales (K Doses) by Type (2024-2024)
Table 22. Latin America RNA Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa RNA Vaccines Sales (K Doses) by Type (2024-2024)
Table 24. Middle East and Africa RNA Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 25. Global RNA Vaccines Sales by Company (2024-2024) & (K Doses)
Table 26. Global RNA Vaccines Sales Share by Company (2024-2024)
Table 27. Global RNA Vaccines Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global RNA Vaccines Revenue Share by Company (2024-2024)
Table 29. Global Market RNA Vaccines Price by Company (2024-2024) & (USD/Dose)
Table 30. Global RNA Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global RNA Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in RNA Vaccines as of 2022)
Table 33. Date of Key Manufacturers Enter into RNA Vaccines Market
Table 34. Key Manufacturers RNA Vaccines Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global RNA Vaccines Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global RNA Vaccines Sales by Region (2024-2024) & (K Doses)
Table 38. Global RNA Vaccines Sales Market Share in Volume by Region (2024-2024)
Table 39. Global RNA Vaccines Sales by Region (2024-2024) & (US$ Million)
Table 40. Global RNA Vaccines Sales Market Share in Value by Region (2024-2024)
Table 41. Global RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 42. Global RNA Vaccines Sales by Region (2024-2034) & (K Doses)
Table 43. Global RNA Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 44. Global RNA Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 45. Global RNA Vaccines Sales Market Share in Value by Region (2024-2034)
Table 46. Global RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2034)
Table 47. Global RNA Vaccines Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global RNA Vaccines Sales by Application (2024-2024) & (K Doses)
Table 49. Global RNA Vaccines Sales Market Share in Volume by Application (2024-2024)
Table 50. Global RNA Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 51. Global RNA Vaccines Sales Market Share in Value by Application (2024-2024)
Table 52. Global RNA Vaccines Price by Application (2024-2024) & (USD/Dose)
Table 53. Global RNA Vaccines Sales by Application (2024-2034) & (K Doses)
Table 54. Global RNA Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 55. Global RNA Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 56. Global RNA Vaccines Sales Market Share in Value by Application (2024-2034)
Table 57. Global RNA Vaccines Price by Application (2024-2034) & (USD/Dose)
Table 58. North America RNA Vaccines Sales by Application (2024-2024) (K Doses)
Table 59. North America RNA Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe RNA Vaccines Sales by Application (2024-2024) (K Doses)
Table 61. Europe RNA Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific RNA Vaccines Sales by Application (2024-2024) (K Doses)
Table 63. Asia-Pacific RNA Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America RNA Vaccines Sales by Application (2024-2024) (K Doses)
Table 65. Latin America RNA Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa RNA Vaccines Sales by Application (2024-2024) (K Doses)
Table 67. Middle East and Africa RNA Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 68. North America RNA Vaccines Sales by Country (2024-2024) & (K Doses)
Table 69. North America RNA Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 70. North America RNA Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 71. North America RNA Vaccines Sales Market Share in Value by Country (2024-2024)
Table 72. North America RNA Vaccines Sales by Country (2024-2034) & (K Doses)
Table 73. North America RNA Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 74. North America RNA Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 75. North America RNA Vaccines Sales Market Share in Value by Country (2024-2034)
Table 76. Europe RNA Vaccines Sales by Country (2024-2024) & (K Doses)
Table 77. Europe RNA Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe RNA Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe RNA Vaccines Sales Market Share in Value by Country (2024-2024)
Table 80. Europe RNA Vaccines Sales by Country (2024-2034) & (K Doses)
Table 81. Europe RNA Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe RNA Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe RNA Vaccines Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific RNA Vaccines Sales by Region (2024-2024) & (K Doses)
Table 85. Asia-Pacific RNA Vaccines Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific RNA Vaccines Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific RNA Vaccines Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific RNA Vaccines Sales by Region (2024-2034) & (K Doses)
Table 89. Asia-Pacific RNA Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific RNA Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific RNA Vaccines Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America RNA Vaccines Sales by Country (2024-2024) & (K Doses)
Table 93. Latin America RNA Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America RNA Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America RNA Vaccines Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America RNA Vaccines Sales by Country (2024-2034) & (K Doses)
Table 97. Latin America RNA Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America RNA Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America RNA Vaccines Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa RNA Vaccines Sales by Country (2024-2024) & (K Doses)
Table 101. Middle East and Africa RNA Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa RNA Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa RNA Vaccines Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa RNA Vaccines Sales by Country (2024-2034) & (K Doses)
Table 105. Middle East and Africa RNA Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa RNA Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa RNA Vaccines Sales Market Share in Value by Country (2024-2034)
Table 108. Moderna Therapeutics Company Information
Table 109. Moderna Therapeutics Introduction and Business Overview
Table 110. Moderna Therapeutics RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 111. Moderna Therapeutics RNA Vaccines Product
Table 112. Moderna Therapeutics Recent Development
Table 113. CureVac Company Information
Table 114. CureVac Introduction and Business Overview
Table 115. CureVac RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 116. CureVac RNA Vaccines Product
Table 117. CureVac Recent Development
Table 118. Translate Bio Company Information
Table 119. Translate Bio Introduction and Business Overview
Table 120. Translate Bio RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 121. Translate Bio RNA Vaccines Product
Table 122. Translate Bio Recent Development
Table 123. BioNTech Company Information
Table 124. BioNTech Introduction and Business Overview
Table 125. BioNTech RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 126. BioNTech RNA Vaccines Product
Table 127. BioNTech Recent Development
Table 128. Sangamo Therapeutics Company Information
Table 129. Sangamo Therapeutics Introduction and Business Overview
Table 130. Sangamo Therapeutics RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 131. Sangamo Therapeutics RNA Vaccines Product
Table 132. Sangamo Therapeutics Recent Development
Table 133. Argos Therapeutics Company Information
Table 134. Argos Therapeutics Introduction and Business Overview
Table 135. Argos Therapeutics RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 136. Argos Therapeutics RNA Vaccines Product
Table 137. Argos Therapeutics Recent Development
Table 138. In-Cell-Art Company Information
Table 139. In-Cell-Art Introduction and Business Overview
Table 140. In-Cell-Art RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 141. In-Cell-Art RNA Vaccines Product
Table 142. In-Cell-Art Recent Development
Table 143. eTheRNA Company Information
Table 144. eTheRNA Introduction and Business Overview
Table 145. eTheRNA RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 146. eTheRNA RNA Vaccines Product
Table 147. eTheRNA Recent Development
Table 148. Ethris Company Information
Table 149. Ethris Introduction and Business Overview
Table 150. Ethris RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 151. Ethris RNA Vaccines Product
Table 152. Ethris Recent Development
Table 153. Tiba Biotechnology Company Information
Table 154. Tiba Biotechnology Introduction and Business Overview
Table 155. Tiba Biotechnology RNA Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2024-2024)
Table 156. Tiba Biotechnology RNA Vaccines Product
Table 157. Tiba Biotechnology Recent Development
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. RNA Vaccines Market Trends
Table 161. RNA Vaccines Market Drivers
Table 162. RNA Vaccines Market Challenges
Table 163. RNA Vaccines Market Restraints
Table 164. RNA Vaccines Distributors List
Table 165. RNA Vaccines Downstream Customers
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. RNA Vaccines Product Picture
Figure 2. Global RNA Vaccines Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global RNA Vaccines Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global RNA Vaccines Sales Status and Outlook (2024-2034) & (K Doses)
Figure 5. Product Picture of Individualized Cancer Treatment MRNA Vaccine
Figure 6. Global Individualized Cancer Treatment MRNA Vaccine Sales YoY Growth (2024-2034) & (K Doses)
Figure 7. Product Picture of Infectious Disease Treatment MRNA Vaccine
Figure 8. Global Infectious Disease Treatment MRNA Vaccine Sales YoY Growth (2024-2034) & (K Doses)
Figure 9. Product Picture of Infection Prevention MRNA Vaccine
Figure 10. Global Infection Prevention MRNA Vaccine Sales YoY Growth (2024-2034) & (K Doses)
Figure 11. Global RNA Vaccines Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global RNA Vaccines Sales Market Share by Type in 2022 & 2034
Figure 13. North America RNA Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. North America RNA Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Europe RNA Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Europe RNA Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific RNA Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific RNA Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Latin America RNA Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Latin America RNA Vaccines Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa RNA Vaccines Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa RNA Vaccines Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by RNA Vaccines Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by RNA Vaccines Revenue in 2022
Figure 25. RNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of Infectious Disease
Figure 27. Global Infectious Disease Sales YoY Growth (2024-2034) & (K Doses)
Figure 28. Product Picture of Cancer
Figure 29. Global Cancer Sales YoY Growth (2024-2034) & (K Doses)
Figure 30. Product Picture of Other
Figure 31. Global Other Sales YoY Growth (2024-2034) & (K Doses)
Figure 32. Global RNA Vaccines Sales by Application (2024-2034) & (US$ Million)
Figure 33. Global RNA Vaccines Sales Market Share by Application in 2022 & 2034
Figure 34. North America RNA Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. North America RNA Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Europe RNA Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Europe RNA Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific RNA Vaccines Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific RNA Vaccines Sales Market Share in Value by Application in 2022
Figure 40. Latin America RNA Vaccines Sales Market Share in Volume by Application in 2022
Figure 41. Latin America RNA Vaccines Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa RNA Vaccines Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. RNA Vaccines Manufacturing Cost Structure
Figure 45. RNA Vaccines Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries